Document Detail


The Impella ventricular assist device: use in patients at high risk for coronary interventions: successful multivessel percutaneous coronary intervention in a 62-year-old high-risk patient.
MedLine Citation:
PMID:  21036108     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
The Impella Recover LP 2.5 (Abiomed, Danvers, MA, USA) is a ventricular assist device that is easily placed and has low adverse events. It helps unload myocardial demand and enables revascularization in patients who are otherwise at extreme risk for percutaneous coronary intervention (PCI). It breaks the cycle of cardiogenic shock and is indicated in patients with low ejection fraction (EF), acute heart failure, and concurrent high-risk factors for intervention or surgery. Many case reports have been published regarding use of this device in high-risk PCIs, but successful intervention in two high-risk vessels in one setting has rarely been reported. We describe such a case report here where two critical lesions in LAD and circumflex arteries were successfully intervened on with the assistance of this device.
Authors:
Punnaiah C Marella; John E Lassetter; Richard R Heuser
Related Documents :
6625718 - Survival and complications following ventricular assist pumping for cardiogenic shock.
17723938 - Patients who have dilated cardiomyopathy must have a trial of bridge to recovery (pro).
2722278 - Prerequisites to salvage profound biventricular failure patients with ventricular assis...
12703888 - Demand dynamic bio-girdling in heart failure: improved efficacy of dynamic cardiomyopla...
8565018 - Hypertension and left-ventricular hypertrophy.
930908 - Continuous electrocardiographic monitoring with holter electrocardiocorder throughout a...
Publication Detail:
Type:  Journal Article     Date:  2010-10-30
Journal Detail:
Title:  Cardiovascular revascularization medicine : including molecular interventions     Volume:  12     ISSN:  1878-0938     ISO Abbreviation:  Cardiovasc Revasc Med     Publication Date:    2011 Jan-Mar
Date Detail:
Created Date:  2011-01-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101238551     Medline TA:  Cardiovasc Revasc Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  69.e9-69.e12     Citation Subset:  IM    
Copyright Information:
Copyright © 2011 Elsevier Inc. All rights reserved.
Affiliation:
Department of Internal Medicine, Banner Estrella Medical Center, 9305 W Thomas Rd., Phoenix, AZ 85037, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Is there a gender disparity in treatment of coronary artery disease?
Next Document:  Currently available methods for platelet function analysis: advantages and disadvantages.